The Discounted Cash Flow (DCF) valuation of Anika Therapeutics Inc (ANIK) is (10.02) USD. With the latest stock price at 14.28 USD, the upside of Anika Therapeutics Inc based on DCF is -170.2%.
Based on the latest price of 14.28 USD and our DCF valuation, Anika Therapeutics Inc (ANIK) is a sell. selling Anika stocks now will result in a potential gain of 170.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 7.1% | 6.1% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (106.27) - (4.18) | (10.02) |
| Upside | -844.2% - -129.2% | -170.2% |